Delivery Order 36F79724D0119-36C24525N0647

Award Date 5/27/25
Potential Completion Date 5/29/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Insmed Inc., a global biopharmaceutical company, for the provision of emergency pharmacy orders. The order, valued at $70,737.80, is for firm fixed-price pharmaceutical products to be delivered by September 30, 2025. The contract is not set aside for any particular business type. Insmed Inc. holds multiple federal contract vehicles with the VA, including a GSA Pharmaceutical and Drugs schedule contract, which allows...
Insmed Incorporated was awarded a $15,182.46 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2. The order is for ARIKAYCE to be delivered to Bridgewater, New Jersey by November 8, 2020. No set-aside designation was used for this award. Insmed will provide the requested pharmaceutical products to support treatment services for veterans...
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ARIKAYCE 590 MG/8.4 ML VIAL 8.4ML, a specialty pharmaceutical product. The contract has a ceiling value of $15,308.51 and runs through October 9, 2024. This appears to be a task order or delivery order off a larger Indefinite Delivery Contract (IDC) vehicle held by...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to ASD Specialty Healthcare, LLC, doing business as Amerisourcebergen, for the provision of Emergency Amikacin Liposome 590mg. The contract has a ceiling value of $20,210.80 and an ultimate completion date of May 30, 2025. This contract is not set-aside and represents an award to a large, established pharmaceutical distribution company that has an extensive history of federal contract awards,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,395.42, is for the delivery of ARIKAYCE 590 MG/8.4 ML VIAL 8.4ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 13, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $95,772.00, was issued by the Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies. The contract is a delivery order under Acorda's Federal Supply Schedule (FSS) contract with the VA, which has a total value of over $16.3 million and is used to procure the company's pharmaceutical products, including Levodopa 42mg inhalation capsules for the treatment of Parkinson's disease. The...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies. The contract, valued at $478,860.00, is a Firm Fixed Price Delivery Order under Acorda's Federal Supply Schedule (FSS) contract with the VA. The contract is for the supply of Levodopa 42mg inhalation capsules, a medication used to treat Parkinson's disease, to the VA's Veterans Health Administration and Veterans...
This firm fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The $478,860.00 contract is for the delivery of pharmaceutical products, specifically Levodopa 42mg inhalation capsules used to treat Parkinson's disease symptoms. The contract is associated with Acorda's Federal Supply Schedule (FSS) contract with the VA, valued...
This federal contract award was made by the U.S. Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The $81,739.77 firm fixed-price delivery order is for the supply of Ventavis (iloprost) 10 mcg/mL inhalation solution, an oral medication used to treat pulmonary arterial hypertension. The contract is part of a larger Indefinite Delivery Vehicle (IDV) under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs....
This is a firm fixed-price Blanket Purchase Agreement (BPA) call issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 7 (VISN 7) to Ariad Pharmaceuticals, Inc. for the order of pharmaceuticals, specifically cancer drugs such as Iclusig (ponatinib) and Lenvima (lenvatinib), for the Department of Veterans Affairs in fiscal year 2017. The contract has a ceiling value of $108,039.90 and an ultimate completion date of September 30, 2017. This contract was awarded...
  • 36F79724D0119
    Federal Supply Schedule
  • 36F79724D0119-36C24525N0647
    Delivery Order

This federal contract award to Insmed Inc., a global biopharmaceutical company, is for the delivery of ARIKAYCE (amikacin) 590mg/8.4ml, a medication used to treat nontuberculous mycobacterial lung infections. The contract, awarded by the U.S. Department of Veterans Affairs (VA), is a firm fixed-price delivery order with a ceiling value of $10,105.40 and an ultimate completion date of May 29, 2025. Insmed has established itself as a key provider of specialized pharmaceutical solutions to the VA, including through a $24.15 million Multiple Award Federal Supply Schedule (FSS) contract and a $49,323.45 Blanket Purchase Agreement (BPA) for ARIKAYCE. This contract award is not designated as a set-aside. The VA, through its Veterans Integrated Service Networks (VISNs), utilizes these contracts to ensure a reliable supply of critical medications to support the healthcare needs of veterans.

Generated 5/28/25, 10:44 AM